首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1085757

全球治療進行性核上性麻痺的市場：按藥物類型、按分銷渠道、按地區規模、份額、前景、機會分析2022-2028

Progressive Supranuclear Palsy Treatment Market, by Drug Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月12日 | 出版商:

Coherent Market Insights | 英文 195 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計進行性核上性麻痺治療市場的增長將受到進行性核上性麻痺 (PSP) 發病率增加的推動。例如，根據美國國家神經疾病和中風研究所於 2020 年 7 月發表的一篇論文，全球 10 萬人中約有 3 至 6 人患有進行性核上性麻痺，而在美國約有 2 萬人患有這種疾病。核上性麻痺。

然而，進行性核上性麻痺的識別和診斷不足預計將阻礙市場增長。

本報告調查和分析全球進行性核上性麻痺治療市場、市場推動者和限制因素、市場機會、COVID-19 的影響、按藥物類型/分銷渠道/地區進行的市場分析，我們提供競爭情況等。

Progressive supranuclear palsy (PSP) is a neurodegenerative disease alike Parkinson's disease. The disease results from damage to nerve cells in the brain. One of the common symptomof the disease include inability to aim and move the eyes properly, where individuals may experience as blurring of vision. It is a rare brain disorder that affects body movement, control of walking i.e. gait and balance, speech, swallowing, vision, mood and behavior, and thinking.

Market Dynamics

Rising incidence of progressive supranuclear palsy (PSP) is expected to drive progressive supranuclear palsy treatment market growth. For instance, according to the National Institute of Neurological Disorders and Stroke, an article published in July 2020, reports that about 3-6 in every 100,000 people have progressive supranuclear palsy worldwide, and around 20,000 U.S. populace are suffering from progressive supranuclear palsy.

However, lack of identification or diagnosis of progressive supranuclear palsy are expected to hinder the market growth. For instance, according to the National Institute of Neurological Disorders and Stroke, an article published in July 2020, states that currently there are no specific laboratory tests or imaging approaches are definitively diagnose progressive supranuclear palsy.

Key features of the study:

This report provides in-depth analysis of the global progressive supranuclear palsy treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global progressive supranuclear palsy treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are AbbVie Inc., Acorda Therapeutics Inc., Biogen Inc., Bristol-Myers Squibb Co., Merck & Co. Inc., UCB Biopharma, AlzProtect, Asceneuron Therapeutics, TauRx Pharmaceuticals, GlaxoSmithKline PLC, Novartis AG, and Teva Pharmaceutical Industries Ltd. among others
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global progressive supranuclear palsy treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global progressive supranuclear palsy treatment market.

Detailed Segmentation:

Global Progressive Supranuclear Palsy Treatment Market, By Drug Type:
- Dopamine
- Anticholinergic Agents
- Tricyclic Antidepressants
- Others
Global Progressive Supranuclear Palsy Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Progressive Supranuclear Palsy Treatment Market, By Region:
- North America
  - By Drug Type:
  - Dopamine
  - Anticholinergic Agents
  - Tricyclic Antidepressants
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Drug Type:
  - Dopamine
  - Anticholinergic Agents
  - Tricyclic Antidepressants
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Drug Type:
  - Dopamine
  - Anticholinergic Agents
  - Tricyclic Antidepressants
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Drug Type:
  - Dopamine
  - Anticholinergic Agents
  - Tricyclic Antidepressants
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Drug Type:
  - Dopamine
  - Anticholinergic Agents
  - Tricyclic Antidepressants
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Drug Type:
  - Dopamine
  - Anticholinergic Agents
  - Tricyclic Antidepressants
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- AbbVie Inc.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Acorda Therapeutics Inc.
- Biogen Inc.
- Bristol-Myers Squibb Co.
- Merck & Co. Inc.
- UCB Biopharma
- AlzProtect
- Asceneuron Therapeutics
- TauRx Pharmaceuticals
- GlaxoSmithKline PLC
- Novartis AG
- Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
Regulatory Scenario
New Product Launches
Collaborations and Agreements
Market Trends

4. Global Progressive Supranuclear Palsy Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Market Scenario
Impact of COVID-19 Market on the Progressive Supranuclear Palsy Treatment Products

5. Global Progressive Supranuclear Palsy Treatment Market, By Drug Type, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Dopamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Anticholinergic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Tricyclic Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Progressive Supranuclear Palsy Treatment Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Progressive Supranuclear Palsy Treatment Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Acorda Therapeutics Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Biogen Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bristol-Myers Squibb Co.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- UCB Biopharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AlzProtect
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Asceneuron Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- TauRx Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline PLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

全球治療進行性核上性麻痺的市場：按藥物類型、按分銷渠道、按地區規模、份額、前景、機會分析2022-2028

Progressive Supranuclear Palsy Treatment Market, by Drug Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目錄

第 1 章調查目標/先決條件

第二章市場範圍

第三章市場動態/監管/趨勢分析

第 4 章全球進行性核外麻痺治療市場：COVID-19 流行病影響

第 5 章全球漸進性核外皮炎治療市場：按藥物類型（2017-2028 年）

第 6 章全球漸進性核週性脊髓灰質炎治療市場：按分銷渠道（2017-2028 年）

第 7 章全球漸進性核外皮炎治療市場：按地區（2017-2028 年）

第8章競爭態勢

第9章章節

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Progressive Supranuclear Palsy Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Progressive Supranuclear Palsy Treatment Market, By Drug Type, 2017 - 2028, (US$ Mn)

6. Global Progressive Supranuclear Palsy Treatment Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

7. Global Progressive Supranuclear Palsy Treatment Market, By Region, 2017 - 2028, (US$ Mn)

8. Competitive Landscape

9. Section

全球治療進行性核上性麻痺的市場：按藥物類型、按分銷渠道、按地區規模、份額、前景、機會分析2022-2028

Progressive Supranuclear Palsy Treatment Market, by Drug Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目錄

第 1 章調查目標/先決條件

第二章市場範圍

第三章市場動態/監管/趨勢分析

第 4 章全球進行性核外麻痺治療市場：COVID-19 流行病影響

第 5 章全球漸進性核外皮炎治療市場：按藥物類型（2017-2028 年）

第 6 章全球漸進性核週性脊髓灰質炎治療市場：按分銷渠道（2017-2028 年）

第 7 章全球漸進性核外皮炎治療市場：按地區（2017-2028 年）

第8章競爭態勢

第9章 章節

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Progressive Supranuclear Palsy Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Progressive Supranuclear Palsy Treatment Market, By Drug Type, 2017 - 2028, (US$ Mn)

6. Global Progressive Supranuclear Palsy Treatment Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

7. Global Progressive Supranuclear Palsy Treatment Market, By Region, 2017 - 2028, (US$ Mn)

8. Competitive Landscape

9. Section

第9章章節